A phase 2 multicentre randomized double-blind parallel-group placebo controlled study to investigate the efficiency and sagety of RO4602522 added to the background therapy of the the acetylcholinester
- Brodtmann, Amy (Primary Chief Investigator (PCI))
Project: Research